Virginia recalls
3753 federal recalls on file affecting Virginia - 678 Virginia-specific plus 3075 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-02-11FDA-DeviceTornierClass IINationwideCheck Tornier orthopedic screws for size mismatch
A specific lot of screws is incorrectly labeled. Screws are labeled as 5.0mmx18mm but actual screws are 5.00mmx14mm. If mismatch is detected during surgery, the issue may cause a minor delay in surgery. If not detected and incorrect screw is used, issue may increase risk of earlier mechanical failure, loosening, and need for revision surgery.
- 2026-02-11FDA-DevicebioMérieuxClass IINationwideStop using affected VITEK 2 susceptibility cards
Potential risk of Quality Control failures and/or false resistant antibiotic results when testing isolates of Enterobacterales/Enterobacteriaceae species and/or Pseudomonas aeruginosa with the identified antibiotic formulations. Issue may lead to QC failure or false resistant results.
- 2026-02-11FDA-DeviceBeckman CoulterClass IINationwideStop using affected Beckman Coulter CellMek systems
Sample preparation system designed to automate staining, lysing, cell washing has a software error that causes samples to be dispensed close to or touching tube bottoms, which could dislodge fluid line, result in sample loss, spillage, make instrument inoperable and will lead to unintentional removal of 60-100 microliters from final sample, may lead to incorrect diagnosis or patient management.
- 2026-02-11FDA-DeviceIntuitive SurgicalClass IINationwideCheck da Vinci surgical system instrument arms
Due to a software implementation error that allowed instruments arms failing an important diagnostic test to remain in clinical use. This test was supposed to be used to detect Universal Surgical Manipulator insertion axis ball screws that exhibit the symptoms of being bent and misaligned which is a precursor to potential ball screw fatigue failure/fraction
- 2026-02-11FDA-DeviceVantiveClass IINationwideStop using affected Vantive Prismaflex TPE2000 sets
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVantiveClass IINationwideStop using affected Prismaflex HF1000 dialyzer sets
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVantiveClass IINationwideStop using affected Prismaflex HF1000 dialyzer sets
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVantiveClass IINationwideCheck your Prismaflex M150 dialyzer sets immediately
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVantiveClass IINationwideStop using Vantive Prismaflex M100 dialyzer sets
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVantiveClass IINationwideCheck your OXIRIS dialyzer set immediately
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVantiveClass IINationwideCheck your Vantive Prismaflex ST150 dialyzer set
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceVantiveClass IINationwideStop using affected Vantive Prismaflex ST100 sets
There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
- 2026-02-11FDA-DeviceOlympusClass IINationwideStop using Olympus electrosurgical knife KD-645L
A deterioration of the cutting knife, including overheating and burning, can contribute to tip breakage during use.
- 2026-02-11FDA-DeviceOlympusClass IINationwideStop using Olympus KD-640L electrosurgical knives
A deterioration of the cutting knife, including overheating and burning, can contribute to tip breakage during use.
- 2026-02-11FDA-DeviceBeckman CoulterClass IINationwideStop using recalled Beckman Coulter diluent lots
Due to specific lots of diluents contributing to elevated platelet Daily Checks background counts cycle with use with analyzers.
- 2026-02-11FDA-DeviceBoston ScientificClass INationwideCheck your AXIOS Stent lot number immediately
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston ScientificClass INationwideContact your doctor about AXIOS Stent
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston ScientificClass INationwideCheck HOT AXIOS Stent lot numbers immediately
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston ScientificClass INationwideContact your doctor about Boston Scientific AXIOS Stent
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston ScientificClass INationwideContact your doctor about AXIOS Stent recall
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-DeviceBoston ScientificClass INationwideStop using Boston Scientific AXIOS Stent
Increased reports of stent deployment and expansion issues. The most common outcome reasonably foreseeable resulting from difficulty deploying the stent is prolongation of the procedure to exchange the device for a new one. The most serious reasonably foreseeable outcome in cases where the first flange is unable to deploy or expand would be a cascade of events resulting in additional intervention, either endoscopic or surgical, to remove the stent and close the puncture site.
- 2026-02-11FDA-FoodB.C. Williams Bakery ServiceClass INationwideStop using B.C. Williams Swiss Chocolate Cake Mix
Undeclared Milk Allergen
- 2026-02-11FDA-FoodB.C. Williams Bakery ServiceClass INationwideStop using B.C. Williams Bakery Bread and Roll Mix
Undeclared Milk Allergen
- 2026-02-11FDA-FoodB.C. Williams Bakery ServiceClass INationwideStop using B.C. Williams Spice Cake Mix
Undeclared Milk Allergen
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
- 2026-02-11FDA-FoodDiva FamClass IINationwideStop using Diva Fam Sea Moss Gel Superfood
potential Clostridium botulinum contamination
Get notified about new Virginia recalls
Free weekly digest. Add Virginia to your profile to filter alerts to your state.
Get the Sunday Brief